Occupational Therapists in Taos, NM Accepting Medicare
5 Occupational Therapists found. Showing 1 - 5
 Deb Jones Therapies, Inc. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1337 Gusdorf Rd, Suite G, Taos, NM 87571 Phone: 575-758-4337 Fax: 575-751-1890 |
 Mrs. Deb L Jones, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1337 Gusdorf Rd, Ste G, Taos, NM 87571 Phone: 575-758-4337 Fax: 575-751-1890 |
Tomacita Tedesco, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 604 Zuni Street, Taos, NM 87571 Phone: 505-310-1703 |
Ms. Elizabeth Anne Roth, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1019 Del Norte Lane, Taos, NM 87571 Phone: 505-758-0165 |
Shannen D Gonzales, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1337 Gusdorf Rd, Taos, NM 87571 Phone: 575-758-4337 |
News Archive
Managing menopausal symptoms in work life extremely difficult for working women
A new national survey released today by Working Mother Media and Pfizer on the impact of menopausal symptoms on women in the workplace finds that managing menopausal symptoms in their work life is extremely or somewhat difficult for nearly half (48 percent) of working women ages 45-65 who have experienced these symptoms in the past year.
Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI
Miracor Medical Systems GmbH announced today that the company has received CE-mark for the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI).
ID Analytics' risk management solutions available on U.S. GSA Schedule
ID Analytics, Inc., the leader in on-demand identity intelligence, announced today its risk management solutions are now available on its' U.S. General Services Administration (GSA) Schedule.
Less-toxic drug combined with fasting may kill cancer cells
Fasting in combination with chemotherapy has already been shown to kill cancer cells, but a pair of new studies in mice suggests that a less-toxic class of drugs combined with fasting may kill breast, colorectal and lung cancer cells equally well.
Copaxone achieves one million patient years of experience in treatment of RRMS
Teva Pharmaceutical Industries, Ltd. announced today that Copaxone® (glatiramer acetate injection), has now achieved one million patient years of experience in the treatment of relapsing-remitting multiple sclerosis (RRMS). This analysis is based on internal data submitted annually to the U.S. Food and Drug Administration (FDA).
› Verified 3 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Occupational Therapists
Podiatrists